Related Experiment Video
Updated: Jan 30, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
MnTBAP treatment ameliorates aldosterone-induced renal injury by regulating mitochondrial dysfunction and NLRP3
Xiao Bi1, Jingjing Wang1, Yuqing Liu1
1Division of Nephrology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University 639 Zhizaoju Road, Shanghai 200011, China.
Abstract:
Aldosterone plays an important role in the pathogenesis of chronic kidney disease (CKD) by directly damaging renal tubular cells. However, the treatment against aldosterone-induced renal injury is still limited. The present study was performed to examine the protection role of MnTBAP in modulating aldosterone-induced renal tubular injury both in vitro and vivo. MtD is induced by aldosterone in HK-2 cells, as evidenced by decreased expression of mtDNA and reduced mitochondrial membrane potential (MMP), which was markedly ameliorated by treatment with MnTBAP. HK-2 cells treated with MnTBAP demonstrated a reduction in cell apoptosis and improvements in cell phenotypic alterations following aldosterone challenge. Treatment with MnTBAP also inhibited the activation of the NLRP3 inflammasome and subsequent release of pro-inflammatory cytokines, IL-1β and IL-18. In addition, MnTBAP treatment of aldosterone-infused mice significantly improved mitochondrial morphology and function, suppressed the activation of NLRP3 inflammasome, reduced renal tubular cell apoptosis, decreased phenotypic alterations, and ameliorated renal apoptosis. We conclude that MnTBAP treatment ameliorates aldosterone-induced renal injury through regulating MtD and NLRP3 inflammsome signalling axis.
Insights
MnTBAP protects against kidney damage caused by aldosterone by improving mitochondrial function and reducing inflammation. This study shows MnTBAP is a potential therapeutic for aldosterone-induced renal injury.
Area of Science:
- Nephrology
- Biochemistry
- Cell Biology
Background:
- Aldosterone contributes to chronic kidney disease (CKD) pathogenesis by damaging renal tubular cells.
- Current treatments for aldosterone-induced renal injury remain limited.
Purpose of the Study:
- To investigate the protective effects of MnTBAP against aldosterone-induced renal tubular injury.
- To explore MnTBAP's mechanisms in vitro and in vivo.
Main Methods:
- Utilized HK-2 cells and aldosterone-infused mice models.
- Assessed mitochondrial DNA (mtDNA) expression, mitochondrial membrane potential (MMP), cell apoptosis, and NLRP3 inflammasome activation.
- Evaluated renal tubular cell apoptosis and phenotypic alterations in vivo.
Main Results:
- MnTBAP treatment ameliorated mitochondrial dysfunction (decreased mtDNA and MMP) in HK-2 cells.
- MnTBAP reduced aldosterone-induced cell apoptosis and phenotypic alterations in HK-2 cells.
- MnTBAP inhibited NLRP3 inflammasome activation and pro-inflammatory cytokine release (IL-1β, IL-18).
- In vivo, MnTBAP improved mitochondrial morphology and function, suppressed NLRP3 inflammasome, reduced renal tubular cell apoptosis, and ameliorated renal injury.
Conclusions:
- MnTBAP demonstrates significant protective effects against aldosterone-induced renal injury.
- MnTBAP exerts its protective role by modulating mitochondrial dysfunction and the NLRP3 inflammasome signaling pathway.
Related Concept Videos
Hormonal Regulation
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Animal Mitochondrial Genetics
GTPases and their Regulation
Large G-proteins,...
Endocrine Signaling
Bacterial Signaling

